93
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Is Palbociclib a cost-effective strategy in the second-line treatment of metastatic breast cancer in Iran?

, , , &
Pages 1201-1210 | Received 10 Jun 2023, Accepted 21 Sep 2023, Published online: 28 Sep 2023

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.